DBV Technologies SA (DBV) Cena akcie a novinky

DomůDBV • EPA

DBV Technologies SA

3,46 €

17. 3., 3:01:28 GMT+1 · EUR · EPA · Prohlášení

AkcieCenný papír kotovaný v FR

Předchozí závěrečná cena

3,57 €

Rozsah během dne

3,46 € - 3,62 €

Rozsah během roku

0,68 € - 4,50 €

Tržní kapitalizace

990,57 mil. EUR

Prům. objem

1,37 mil.

P/E poměr

Dividendový výnos

Primární burza

EPA

Zprávy z trhů

Simply Wall St

před 24 minutami

How Pampers’ New AMORE Premium Diaper Line At Procter & Gamble (PG) Has Changed Its Investment Story

0,98 %

MarketBeat

před 16 minutami

American Resources (NASDAQ:AREC) Stock Price Up 0.6% - Here's What Happened

Wall Street sees best day since the war in Iran began

The Motley Fool

před 6 hodinami

The Stock Market Sounds an Alarm for the First Time in 25 Years. Here Is What History Says the S&P 500 Will Do in 2026.

After a challenging March, will St. Patrick’s Day deliver a lift for stocks?

.INX

1,01 %

Chattanooga Times Free Press

před 8 hodinami

Falling oil prices send Wall Street toward its best day since the Iran war began

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia

Založeno

29. 3. 2002

Web

dbv-technologies.com

Zaměstnanci

117